Cargando…
Who Will Pay for the COVID-19 Vaccines for Africa?
Africa’s health systems are strained by the COVID-19 pandemic. There are global efforts toward the development and trial of COVID-19 vaccines. However, considering the challenges and economic conditions of African nations, there could be limited access and availability of the vaccines on the contine...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941795/ https://www.ncbi.nlm.nih.gov/pubmed/33427194 http://dx.doi.org/10.4269/ajtmh.20-1506 |
_version_ | 1783662192985374720 |
---|---|
author | Lucero-Prisno, Don Eliseo Ogunkola, Isaac Olushola Imo, Uchenna Frank Adebisi, Yusuff Adebayo |
author_facet | Lucero-Prisno, Don Eliseo Ogunkola, Isaac Olushola Imo, Uchenna Frank Adebisi, Yusuff Adebayo |
author_sort | Lucero-Prisno, Don Eliseo |
collection | PubMed |
description | Africa’s health systems are strained by the COVID-19 pandemic. There are global efforts toward the development and trial of COVID-19 vaccines. However, considering the challenges and economic conditions of African nations, there could be limited access and availability of the vaccines on the continent. This will be the result of high cost and technical requirements to acquire the vaccines. There are indications that possible donor funding for COVID-19 vaccines from rich countries maybe put off considering the various challenges they face currently and the moves they are making in response to the disease. The issue of justice in health for protecting the vulnerable populations and regions also supports the need for COVID-19 vaccine availability on the African continent. Means to achieve uniform control of the disease burden across the globe should be adopted. Governments of African nations should also scale up their efforts toward COVID-19 vaccine acquisition and utilization through viable efforts. It is therefore important to assist the African continent in acquiring the COVID-19 vaccines by leveling all power dynamics that will affect access and distribution. |
format | Online Article Text |
id | pubmed-7941795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The American Society of Tropical Medicine and Hygiene |
record_format | MEDLINE/PubMed |
spelling | pubmed-79417952021-03-26 Who Will Pay for the COVID-19 Vaccines for Africa? Lucero-Prisno, Don Eliseo Ogunkola, Isaac Olushola Imo, Uchenna Frank Adebisi, Yusuff Adebayo Am J Trop Med Hyg Perspective Piece Africa’s health systems are strained by the COVID-19 pandemic. There are global efforts toward the development and trial of COVID-19 vaccines. However, considering the challenges and economic conditions of African nations, there could be limited access and availability of the vaccines on the continent. This will be the result of high cost and technical requirements to acquire the vaccines. There are indications that possible donor funding for COVID-19 vaccines from rich countries maybe put off considering the various challenges they face currently and the moves they are making in response to the disease. The issue of justice in health for protecting the vulnerable populations and regions also supports the need for COVID-19 vaccine availability on the African continent. Means to achieve uniform control of the disease burden across the globe should be adopted. Governments of African nations should also scale up their efforts toward COVID-19 vaccine acquisition and utilization through viable efforts. It is therefore important to assist the African continent in acquiring the COVID-19 vaccines by leveling all power dynamics that will affect access and distribution. The American Society of Tropical Medicine and Hygiene 2021-03 2021-01-07 /pmc/articles/PMC7941795/ /pubmed/33427194 http://dx.doi.org/10.4269/ajtmh.20-1506 Text en © The American Society of Tropical Medicine and Hygiene https://creativecommons.org/licenses/by-nc/4.0/ Open Access statement. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and reproduction in any medium for non-commercial purposes, provided the original author and source are credited, a link to the CC License is provided, and changes – if any – are indicated. |
spellingShingle | Perspective Piece Lucero-Prisno, Don Eliseo Ogunkola, Isaac Olushola Imo, Uchenna Frank Adebisi, Yusuff Adebayo Who Will Pay for the COVID-19 Vaccines for Africa? |
title | Who Will Pay for the COVID-19 Vaccines for Africa? |
title_full | Who Will Pay for the COVID-19 Vaccines for Africa? |
title_fullStr | Who Will Pay for the COVID-19 Vaccines for Africa? |
title_full_unstemmed | Who Will Pay for the COVID-19 Vaccines for Africa? |
title_short | Who Will Pay for the COVID-19 Vaccines for Africa? |
title_sort | who will pay for the covid-19 vaccines for africa? |
topic | Perspective Piece |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941795/ https://www.ncbi.nlm.nih.gov/pubmed/33427194 http://dx.doi.org/10.4269/ajtmh.20-1506 |
work_keys_str_mv | AT luceroprisnodoneliseo whowillpayforthecovid19vaccinesforafrica AT ogunkolaisaacolushola whowillpayforthecovid19vaccinesforafrica AT imouchennafrank whowillpayforthecovid19vaccinesforafrica AT adebisiyusuffadebayo whowillpayforthecovid19vaccinesforafrica |